CASDIN CAPITAL, LLC Alnylam Pharmaceuticals, Inc. Transaction History

CASDIN CAPITAL, LLC portfolio value:

$129.70M
portfolio value

CASDIN CAPITAL, LLC quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -19.50% -157K shares 12.29M $200.16 648K
Q2 2022 share Decrease -19.50% -195K shares -45.88M $145.85 805K
Q1 2022 share 0.00% 0 shares -6.29M $163.29 1M
Q4 2021 share 0.00% 0 shares -19.23M $171.03 1M
Q3 2021 share 0.00% 0 shares 19.29M $188.81 1M
Q2 2021 share Increase +13.64% 120K shares 45.27M $169.52 1M
Q1 2021 share Increase +12.82% 100K shares 22.87M $141.19 880K
Q4 2020 share Increase +25.81% 160K shares 11.10M $129.97 780K
Q3 2020 share Increase +12.73% 70K shares 8.81M $145.6 620K
Q2 2020 share Decrease -5.98% -35K shares 17.78M $148.11 550K
Q1 2020 share Increase +13.59% 70K shares 4.36M $108.85 585K
Q4 2019 share Decrease -14.17% -85K shares 11.06M $115.17 515K
Q3 2019 share Decrease -7.69% -50K shares 1.08M $80.42 600K
Q2 2019 share Increase +46.07% 205K shares 5.57M $72.56 650K
Q1 2019 share Increase +25.35% 90K shares 15.70M $93.45 445K
Q4 2018 share Increase +31.48% 85K shares 2.25M $72.91 355K
Q3 2018 share 0.00% 0 shares -2.96M $87.52 270K
Q2 2018 share Increase +8.00% 20K shares -3.18M $98.49 270K
Q1 2018 share Increase +25.00% 50K shares 4.36M $119.1 250K
Q4 2017 share 0.00% 0 shares 1.91M $127.05 200K
Q3 2017 share Increase +90.48% 95K shares 15.12M $117.49 200K
Q2 2017 share Increase +90.91% 50K shares 5.55M $79.76 105K
Q1 2017 share Decrease -35.29% -30K shares -363K $51.25 55K
Q4 2016 share Increase +117.95% 46K shares 539K $37.44 85K
Q3 2016 share Decrease -46.21% -33.5K shares -1.38M $67.78 39K
Q2 2016 share Decrease -19.44% -17.5K shares -1.62M $55.49 72.5K
Q1 2016 share Increase +50.00% 30K shares 1K $62.77 90K